Retinoic acid receptor-mediated signaling protects cardiomyocytes from hyperglycemia induced apoptosis: Role of the renin-angiotensin system

Journal of Cellular Physiology

Volumn 226, Issue 5, 2011, Pages 1292-1307

  Guleria, Rakeshwar S ^a   Choudhary, Rashmi ^b   Tanaka, Takemi ^c   Baker, Kenneth M ^a   Pan, Jing ^a  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN TYPE 1 RECEPTOR; ANGIOTENSINOGEN; GLUCOSE; REACTIVE OXYGEN METABOLITE; RENIN; RETINOIC ACID RECEPTOR ALPHA; RETINOID X RECEPTOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HEART MUSCLE CELL; HYPERGLYCEMIA; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STATISTICAL SIGNIFICANCE; ZUCKER DIABETIC FATTY RAT;

ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BLOOD GLUCOSE; CELLS, CULTURED; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; MALE; MYOCYTES, CARDIAC; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; RATS, ZUCKER; REACTIVE OXYGEN SPECIES; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, RETINOIC ACID; RENIN-ANGIOTENSIN SYSTEM; RETINOID X RECEPTOR ALPHA; RNA INTERFERENCE; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS; TRETINOIN;

RATTUS;

EID: 79951790915     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22457     Document Type: Article

References (73)

1. Baena RM, Campoy C, Bayes R, Blanca E, Fernandez JM, Molina-Font JA. 2002. Vitamin A, retinol binding protein and lipids in type 1 diabetes mellitus. Eur J Clin Nutr 56: 44-50.
2. Baker KM, Chernin MI, Schreiber T, Sanghi S, Haiderzaidi S, Booz GW, Dostal DE, Kumar R. 2004. Evidence of a novel intracrine mechanism in angiotensin II-induced cardiac hypertrophy. Regul Pept 120: 5-13.
3. Baraka A, AbdelGawad H. 2010. Targeting apoptosis in the heart of streptozotocin-induced diabetic rats. J Cardiovasc Pharmacol Ther 15: 175-181.
4. Bastien J, Rochette-Egly C. 2004. Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene 328: 1-16.
5. Basu TK, Basualdo C. 1997. Vitamin A homeostasis and diabetes mellitus. Nutrition 13: 804-806.
6. Basualdo CG, Wein EE, Basu TK. 1997. Vitamin A (retinol) status of first nation adults with non-insulin-dependent diabetes mellitus. J Am Coll Nutr 16: 39-45.
7. Boudjelal M, Voorhees JJ, Fisher GJ. 2002. Retinoid signaling is attenuated by proteasome-mediated degradation of retinoid receptors in human keratinocyte HaCaT cells. Exp Cell Res 274: 130-137.
8. Bruck N, Bastien J, Bour G, Tarrade A, Plassat JL, Bauer A, Adam-Stitah S, Rochette-Egly C. 2005. Phosphorylation of the retinoid x receptor at the omega loop, modulates the expression of retinoic-acid-target genes with a promoter context specificity. Cell Signal 17: 1229-1239.
9. Cai L, Kang YJ. 2003. Cell death and diabetic cardiomyopathy. Cardiovasc Toxicol 3: 219-228.
10. Cai L, Wang Y, Zhou G, Chen T, Song Y, Li X, Kang YJ. 2006. Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy. J Am Coll Cardiol 48: 1688-1697.
11. Cho YM, Youn BS, Lee H, Lee N, Min SS, Kwak SH, Lee HK, Park KS. 2006. Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes. Diabetes Care 29: 2457-2461.
12. Choudhary R, Baker KM, Pan J. 2008a. All-trans retinoic acid prevents angiotensin II- and mechanical stretch-induced reactive oxygen species generation and cardiomyocyte apoptosis. J Cell Physiol 215: 172-181.
13. Choudhary R, Palm-Leis A, Scott RC 3rd, Guleria RS, Rachut E, Baker KM, Pan J. 2008b. All-trans retinoic acid prevents development of cardiac remodeling in aortic banded rats by inhibiting the renin-angiotensin system. Am J Physiol Heart Circ Physiol 294: H633-644.
14. Claycomb WC, Palazzo MC. 1980. Culture of the terminally differentiated adult cardiac muscle cell: a light and scanning electron microscope study. Dev Biol 80: 466-482.
15. Dawson MI. 2004. Synthetic retinoids and their nuclear receptors. Curr Med Chem Anticancer Agents 4: 199-230.
16. Dawson MI, Zhang XK. 2002. Discovery and design of retinoic acid receptor and retinoid X receptor class- and subtype-selective synthetic analogs of all-trans-retinoic acid and 9-cis-retinoic acid. Curr Med Chem 9: 623-637.
17. Dechow C, Morath C, Peters J, Lehrke I, Waldherr R, Haxsen V, Ritz E, Wagner J. 2001. Effects of all-trans retinoic acid on renin-angiotensin system in rats with experimental nephritis. Am J Physiol Renal Physiol 281: F909-919.
18. Delescluse C, Cavey MT, Martin B, Bernard BA, Reichert U, Maignan J, Darmon M, Shroot B. 1991. Selective high affinity retinoic acid receptor alpha or beta-gamma ligands. Mol Pharmacol 40: 556-562.
19. Delmotte MH, Tahayato A, Formstecher P, Lefebvre P. 1999. Serine 157, a retinoic acid receptor alpha residue phosphorylated by protein kinase C in vitro, is involved in RXR.RARalpha heterodimerization and transcriptional activity. J Biol Chem 274: 38225-38231.
20. Devereux RB, Roman MJ, Paranicas M, O'Grady MJ, Lee ET, Welty TK, Fabsitz RR, Robbins D, Rhoades ER, Howard BV. 2000. Impact of diabetes on cardiac structure and function: the strong heart study. Circulation 101: 2271-2276.
21. Dyson E, Sucov HM, Kubalak SW, Schmid-Schonbein GW, DeLano FA, Evans RM, Ross J Jr, Chien KR. 1995. Atrial-like phenotype is associated with embryonic ventricular failure in retinoid X receptor alpha -/- mice. Proc Natl Acad Sci U S A 92: 7386-7390.
22. Dzau VJ. 2001. Theodore Cooper lecture: tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension 37: 1047-1052.
23. Ebisawa M, Umemiya H, Ohta K, Fukasawa H, Kawachi E, Christoffel G, Gronemeyer H, Tsuji M, Hashimoto Y, Shudo K, Kagechika H. 1999. Retinoid X receptor-antagonistic diazepinylbenzoic acids. Chem Pharm Bull (Tokyo) 47: 1778-1786.
24. Fiordaliso F, Bianchi R, Staszewsky L, Cuccovillo I, Doni M, Laragione T, Salio M, Savino C, Melucci S, Santangelo F, Scanziani E, Masson S, Ghezzi P, Latini R. 2004. Antioxidant treatment attenuates hyperglycemia-induced cardiomyocyte death in rats. J Mol Cell Cardiol 37: 959-968.
25. Green DR, Reed JC. 1998. Mitochondria and apoptosis. Science 281: 1309-1312.
26. Haxsen V, Adam-Stitah S, Ritz E, Wagner J. 2001. Retinoids inhibit the actions of angiotensin II on vascular smooth muscle cells. Circ Res 88: 637-644.
27. Ho KK, Pinsky JL, Kannel WB, Levy D. 1993. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol 22: 6A-13A.
28. Hsieh TJ, Zhang SL, Filep JG, Tang SS, Ingelfinger JR, Chan JS. 2002. High glucose stimulates angiotensinogen gene expression via reactive oxygen species generation in rat kidney proximal tubular cells. Endocrinology 143: 2975-2985.
29. Ilercil A, Devereux RB, Roman MJ, Paranicas M, O'Grady MJ, Welty TK, Robbins DC, Fabsitz RR, Howard BV, Lee ET. 2001. Relationship of impaired glucose tolerance to left ventricular structure and function: The Strong Heart Study. Am Heart J 141: 992-998.
30. Johnson AT, Klein ES, Gillett SJ, Wang L, Song TK, Pino ME, Chandraratna RA. 1995. Synthesis and characterization of a highly potent and effective antagonist of retinoic acid receptors. J Med Chem 38: 4764-4767.
31. Karnik AA, Fields AV, Shannon RP. 2007. Diabetic cardiomyopathy. Curr Hypertens Rep 9: 467-473.
32. Kastner P, Messaddeq N, Mark M, Wendling O, Grondona JM, Ward S, Ghyselinck N, Chambon P. 1997. Vitamin A deficiency and mutations of RXRalpha, RXRbeta and RARalpha lead to early differentiation of embryonic ventricular cardiomyocytes. Development 124: 4749-4758.
33. Katare RG, Caporali A, Oikawa A, Meloni M, Emanueli C, Madeddu P. 2010. Vitamin B1 analog benfotiamine prevents diabetes-induced diastolic dysfunction and heart failure through Akt/Pim-1-mediated survival pathway. Circ Heart Fail 3: 294-305.
34. Klein ES, Pino ME, Johnson AT, Davies PJ, Nagpal S, Thacher SM, Krasinski G, Chandraratna RA. 1996. Identification and functional separation of retinoic acid receptor neutral antagonists and inverse agonists. J Biol Chem 271: 22692-22696.
35. Kopf E, Plassat JL, Vivat V, de The H, Chambon P, Rochette-Egly C. 2000. Dimerization with retinoid X receptors and phosphorylation modulate the retinoic acid-induced degradation of retinoic acid receptors alpha and gamma through the ubiquitin-proteasome pathway. J Biol Chem 275: 33280-33288.
36. Krezel W, Dupe V, Mark M, Dierich A, Kastner P, Chambon P. 1996. RXR gamma null mice are apparently normal and compound RXR alpha +/-/RXR beta -/-/RXR gamma -/- mutant mice are viable. Proc Natl Acad Sci U S A 93: 9010-9014.
37. Kuethe F, Sigusch HH, Bornstein SR, Hilbig K, Kamvissi V, Figulla HR. 2007. Apoptosis in patients with dilated cardiomyopathy and diabetes: a feature of diabetic cardiomyopathy? Horm Metab Res 39: 672-676.
38. Leibowitz MD, Ardecky RJ, Boehm MF, Broderick CL, Carfagna MA, Crombie DL, D'Arrigo J, Etgen GJ, Faul MM, Grese TA, Havel H, Hein NI, Heyman RA, Jolley D, Klausing K, Liu S, Mais DE, Mapes CM, Marschke KB, Michellys PY, Montrose-Rafizadeh C, Ogilvie KM, Pascual B, Rungta D, Tyhonas JS, Urcan MS, Wardlow M, Yumibe N, Reifel-Miller A. 2006. Biological characterization of a heterodimer-selective retinoid X receptor modulator: potential benefits for the treatment of type 2 diabetes. Endocrinology 147: 1044-1053.
39. Li CJ, Zhang QM, Li MZ, Zhang JY, Yu P, Yu DM. 2009. Attenuation of myocardial apoptosis by alpha-lipoic acid through suppression of mitochondrial oxidative stress to reduce diabetic cardiomyopathy. Chin Med J (Engl) 122: 2580-2586.
40. Li E, Sucov HM, Lee KF, Evans RM, Jaenisch R. 1993. Normal development and growth of mice carrying a targeted disruption of the alpha 1 retinoic acid receptor gene. Proc Natl Acad Sci U S A 90: 1590-1594.
41. Lohnes D, Kastner P, Dierich A, Mark M, LeMeur M, Chambon P. 1993. Function of retinoic acid receptor gamma in the mouse. Cell 73: 643-658.
42. Lohnes D, Mark M, Mendelsohn C, Dolle P, Dierich A, Gorry P, Gansmuller A, Chambon P. 1994. Function of the retinoic acid receptors (RARs) during development (I). Craniofacial and skeletal abnormalities in RAR double mutants. Development 120: 2723-2748.
43. Luo J, Pasceri P, Conlon RA, Rossant J, Giguere V. 1995. Mice lacking all isoforms of retinoic acid receptor beta develop normally and are susceptible to the teratogenic effects of retinoic acid. Mech Dev 53: 61-71.
44. Marra G, Cotroneo P, Pitocco D, Manto A, Di Leo MA, Ruotolo V, Caputo S, Giardina B, Ghirlanda G, Santini SA. 2002. Early increase of oxidative stress and reduced antioxidant defenses in patients with uncomplicated type 1 diabetes: a case for gender difference. Diabetes Care 25: 370-375.
45. Mendelsohn C, Lohnes D, Decimo D, Lufkin T, LeMeur M, Chambon P, Mark M. 1994. Function of the retinoic acid receptors (RARs) during development (II). Multiple abnormalities at various stages of organogenesis in RAR double mutants. Development 120: 2749-2771.
46. Montessuit C, Papageorgiou I, Lerch R. 2008. Nuclear receptor agonists improve insulin responsiveness in cultured cardiomyocytes through enhanced signaling and preserved cytoskeletal architecture. Endocrinology 149: 1064-1074.
47. Mukherjee R, Davies PJ, Crombie DL, Bischoff ED, Cesario RM, Jow L, Hamann LG, Boehm MF, Mondon CE, Nadzan AM, Paterniti JR Jr, Heyman RA. 1997. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Nature 386: 407-410.
48. Nickenig G, Harrison DG. 2002. The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: part I: oxidative stress and atherogenesis. Circulation 105: 393-396.
49. Palm-Leis A, Singh US, Herbelin BS, Olsovsky GD, Baker KM, Pan J. 2004. Mitogen-activated protein kinases and mitogen-activated protein kinase phosphatases mediate the inhibitory effects of all-trans retinoic acid on the hypertrophic growth of cardiomyocytes. J Biol Chem 279: 54905-54917.
50. Penckofer S, Schwertz D, Florczak K. 2002. Oxidative stress and cardiovascular disease in type 2 diabetes: the role of antioxidants and pro-oxidants. J Cardiovasc Nurs 16: 68-85.
51. Rajamani U, Essop MF. 2010. Hyperglycemia-mediated activation of the hexosamine biosynthetic pathway results in myocardial apoptosis. Am J Physiol Cell Physiol 299: C139-147.
52. Ricci C, Jong CJ, Schaffer SW. 2008. Proapoptotic and antiapoptotic effects of hyperglycemia: role of insulin signaling. Can J Physiol Pharmacol 86: 166-172.
53. Sakoda M, Ichihara A, Kurauchi-Mito A, Narita T, Kinouchi K, Murohashi-Bokuda K, Saleem MA, Nishiyama A, Suzuki F, Itoh H. 2010. Aliskiren inhibits intracellular angiotensin II levels without affecting (pro)renin receptor signals in human podocytes. Am J Hypertens 23: 575-580.
54. Schaffer SW, Croft CB, Solodushko V. 2000. Cardioprotective effect of chronic hyperglycemia: effect on hypoxia-induced apoptosis and necrosis. Am J Physiol Heart Circ Physiol 278: H1948-1954.
55. Shan P, Pu J, Yuan A, Shen L, Chai D, He B. 2008. RXR agonists inhibit oxidative stress-induced apoptosis in H9c2 rat ventricular cells. Biochem Biophys Res Commun 375: 628-633.
56. Shen E, Li Y, Shan L, Zhu H, Feng Q, Arnold JM, Peng T. 2009. Rac1 is required for cardiomyocyte apoptosis during hyperglycemia. Diabetes 58: 2386-2395.
57. Singh VP, Le B Bhat VB, Baker KM, Kumar R. 2007. High-glucose-induced regulation of intracellular ANG II synthesis and nuclear redistribution in cardiac myocytes. Am J Physiol Heart Circ Physiol 293: H939-948.
58. Song Y, Du Y, Prabhu SD, Epstein PN. 2007. Diabetic Cardiomyopathy in OVE26 Mice Shows Mitochondrial ROS Production and Divergence Between In Vivo and In Vitro Contractility. Rev Diabet Stud 4: 159-168.
59. Stosic-Grujicic S, Cvjeticanin T, Stojanovic I. 2009. Retinoids differentially regulate the progression of autoimmune diabetes in three preclinical models in mice. Mol Immunol 47: 79-86.
60. Subbarayan V, Mark M, Messadeq N, Rustin P, Chambon P, Kastner P. 2000. RXRalpha overexpression in cardiomyocytes causes dilated cardiomyopathy but fails to rescue myocardial hypoplasia in RXRalpha-null fetuses. J Clin Invest 105: 387-394.
61. Sucov HM, Dyson E, Gumeringer CL, Price J, Chien KR, Evans RM. 1994. RXR alpha mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis. Genes Dev 8: 1007-1018.
62. Takeda K, Ichiki T, Funakoshi Y, Ito K, Takeshita A. 2000. Downregulation of angiotensin II type 1 receptor by all-trans retinoic acid in vascular smooth muscle cells. Hypertension 35: 297-302.
63. Tuitoek PJ, Ziari S, Tsin AT, Rajotte RV, Suh M, Basu TK. 1996. Streptozotocin-induced diabetes in rats is associated with impaired metabolic availability of vitamin A (retinol). Br J Nutr 75: 615-622.
64. Van YH, Lee WH, Ortiz S, Lee MH, Qin HJ, Liu CP. 2009. All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells. Diabetes 58: 146-155.
65. Wang HJ, Zhu YC, Yao T. 2002. Effects of all-trans retinoic acid on angiotensin II-induced myocyte hypertrophy. J Appl Physiol 92: 2162-2168.
66. Wang P, Chatham JC. 2004. Onset of diabetes in Zucker diabetic fatty (ZDF) rats leads to improved recovery of function after ischemia in the isolated perfused heart. Am J Physiol Endocrinol Metab 286: E725-736.
67. Wang X. 2001. The expanding role of mitochondria in apoptosis. Genes Dev 15: 2922-2933.
68. Wu J, Garami M, Cheng T, Gardner DG. 1996. 1, 25(OH)2 vitamin D3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes. J Clin Invest 97: 1577-1588.
69. Xu G, Takashi E, Kudo M, Ishiwata T, Naito Z. 2004. Contradictory effects of short- and long-term hyperglycemias on ischemic injury of myocardium via intracellular signaling pathway. Exp Mol Pathol 76: 57-65.
70. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L, Kahn BB. 2005. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436: 356-362.
71. Zhong JC, Huang DY, Liu GF, Jin HY, Yang YM, Li YF, Song XH, Du K. 2005. Effects of all-trans retinoic acid on orphan receptor APJ signaling in spontaneously hypertensive rats. Cardiovasc Res 65: 743-750.
72. Zhong JC, Huang DY, Yang YM, Li YF, Liu GF, Song XH, Du K. 2004. Upregulation of angiotensin-converting enzyme 2 by all-trans retinoic acid in spontaneously hypertensive rats. Hypertension 44: 907-912.
73. Zhou MD, Sucov HM, Evans RM, Chien KR. 1995. Retinoid-dependent pathways suppress myocardial cell hypertrophy. Proc Natl Acad Sci U S A 92: 7391-7395.